Fiji vs Sur: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Sur
62.0%
in 2024
Fiji rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Sur
How they compare
Fiji currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Fiji's figure about 1.6 times Sur's.
The two have swapped places 8 times across 15 shared years of data; in 2009 it was Fiji ahead.
Fiji ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Fiji | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.0% | 100.0% | Fiji |
| 2010s | 49.8% | 53.0% | 3.2% | Sur |
| 2020s | 81.8% | 78.4% | 3.4% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Sur?
- Fiji, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Sur?
- 38.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Sur?
- 15 years are reported by both, from 2009 to 2024.
- How do Fiji and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.